The Rheumatology Podcast

Dr Eunice Victoria Co asks Dr Josep Ribalta (Reus, Spain) about his recent study, where endothelial cells were incubated with low-density lipoprotein from active vs. inactive patients with systemic lupus erythematosus. Their discussion includes the key findings from the study, how best to measure endothelial cell function, and the team’s future research.

Dr Eunice Victoria Co asks Dr Josep Ribalta (Reus, Spain) about his recent study, where endothelial cells were incubated with low-density lipoprotein from active vs. inactive patients with systemic lupus erythematosus. Their discussion includes the key findings from the study, how best to measure endothelial cell function, and the team’s future research.

Dr Puja Mehta asks Dr Elizabeth Price (Great Western Hospital, Swindon, UK) about the upcoming BSR Sjögren’s syndrome guideline. Dr Price explains why a new guideline is needed, the challenges the guideline group hopes to address, and where to access more information about Sjögren’s syndrome.

Dr Puja Mehta asks Dr Elizabeth Price (Great Western Hospital, Swindon, UK) about the upcoming BSR Sjögren’s syndrome guideline. Dr Price explains why a new guideline is needed, the challenges the guideline group hopes to address, and where to access more information about Sjögren’s syndrome.

Dr Herman Tam asks Dr Matthew Basiaga (Mayo Clinic, Rochester, MN, US) about his recent paper, which applied the 2016 ACR/EULAR classification criteria to a cohort of patients with paediatric Sjögren’s syndrome. They discuss the key findings from the study, how to develop better paediatric criteria, and important implications for clinicians.

Clare Jacklin (NRAS, UK) and Dr. James Galloway (KCL, UK) reflect on findings from the BSR National Early Inflammatory Arthritis Audit (NEIAA). They discuss the recent Short Report on Ethnicity, the impact of the pandemic on data collection and rheumatology services, and the importance of patient participation and PROMs.

Prof. Hector Chinoy (Manchester, UK), Dr Jesús Loarce-Martos (Madrid, Spain) and Dr James Lilleker (Manchester, UK) talk to Dr Marwan Bukhari about their recent paper. They discuss the history of myositis classification criteria, results from their study, and implications for subtyping idiopathic inflammatory myopathy in clinical practice.

Prof. Hector Chinoy (Manchester, UK), Dr Jesús Loarce-Martos (Madrid, Spain) and Dr James Lilleker (Manchester, UK) talk to Dr Marwan Bukhari about their recent paper. They discuss the history of myositis classification criteria, results from their study, and implications for subtyping idiopathic inflammatory myopathy in clinical practice.

Prof. Hector Chinoy (Manchester, UK), Dr Jesús Loarce-Martos (Madrid, Spain) and Dr James Lilleker (Manchester, UK) talk to Dr Marwan Bukhari about their recent paper. They discuss the history of myositis classification criteria, results from their study, and implications for subtyping idiopathic inflammatory myopathy in clinical practice.

Dr Ai Lyn Tan talks to Dr Rosemary Hollick (Aberdeen, UK) about her recent paper, which examines the feasibility and acceptability of telephone-based cognitive behavioural therapy for patients with axial spondyloarthritis. They discuss who might best engage with and benefit from this intervention, plus the importance of working with patient partners. This is a Rheumatology Advances in Practice podcast.